{
    "ticker": "BPTH",
    "name": "Bionano Genomics, Inc.",
    "description": "Bionano Genomics, Inc. is a biotechnology company focused on advancing the field of genome analysis and precision medicine through its innovative genome mapping technology. Founded in 2003 and headquartered in San Diego, California, Bionano aims to provide researchers and clinicians with tools to understand the genetic basis of diseases more effectively. The company's flagship product, the Saphyr system, utilizes optical genome mapping to detect structural variations in DNA that are often missed by traditional sequencing methods. This technology enables scientists to gain deeper insights into genetic disorders, cancer, and other diseases, facilitating improved diagnosis and treatment options. Bionano is committed to enhancing genomic research and has established collaborations with leading academic institutions and clinical laboratories to validate its technology in various applications. The company's mission is to empower researchers with cutting-edge tools that can ultimately lead to better patient outcomes and a more profound understanding of human genetics.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2003",
    "website": "https://www.bionanogenomics.com",
    "ceo": "Erik Holmlin",
    "social_media": {
        "twitter": "https://twitter.com/BionanoGenomics",
        "linkedin": "https://www.linkedin.com/company/bionano-genomics/"
    },
    "investor_relations": "https://investors.bionanogenomics.com",
    "key_executives": [
        {
            "name": "Erik Holmlin",
            "position": "CEO"
        },
        {
            "name": "Kathy H. L. G. G. J. Wong",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genome Mapping",
            "products": [
                "Saphyr System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Bionano Genomics, Inc. | Advancing Genome Analysis",
        "meta_description": "Explore Bionano Genomics, Inc., a leader in genome mapping technology. Discover how Bionano is transforming genomic research with innovative solutions.",
        "keywords": [
            "Bionano Genomics",
            "Genome Mapping",
            "Biotechnology",
            "Precision Medicine",
            "Genomics"
        ]
    },
    "faq": [
        {
            "question": "What is Bionano Genomics known for?",
            "answer": "Bionano Genomics is known for its optical genome mapping technology that detects structural variations in DNA."
        },
        {
            "question": "Who is the CEO of Bionano Genomics?",
            "answer": "Erik Holmlin is the CEO of Bionano Genomics, Inc."
        },
        {
            "question": "Where is Bionano Genomics headquartered?",
            "answer": "Bionano Genomics is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Bionano's main products?",
            "answer": "Bionano's main product is the Saphyr system for genome mapping."
        },
        {
            "question": "When was Bionano Genomics founded?",
            "answer": "Bionano Genomics was founded in 2003."
        }
    ],
    "competitors": [
        "ILMN",
        "PACB",
        "REGN"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "VRTX"
    ]
}